Farrah Mateen, MD, PhD, of the Multiple Sclerosis Clinic at Mass General, discusses treatment options for MS patients and how research could help in diagnosing and monitoring the disease.
Departments, Centers, & Programs:
15 Parkman Street
Boston, MA 02114-3117
- PhD, Johns Hopkins Bloomberg School of Public Health
- MD, University of Saskatchewan College of Medicine
- Residency, Mayo Clinic
- Fellowship, The Johns Hopkins Hospital
American Board Certifications
- Neurology, American Board of Psychiatry and Neurology
Accepted Insurance Plans
Note: This provider may accept more insurance plans than shown; please call the practice to find out if your plan is accepted.
Dr. Mateen performs research dedicated to the understanding of: (1) Multiple sclerosis and related central nervous system demyelinating diseases to study new treatments and biomarkers for patients ; and (2) Neurological diseases from a global health perspective with a focus on resource-limited settings.
Dr. Mateen's longterm research goal is to advance neurological care through low-cost, evidence-based interventions, informed by detailed clinical-epidemiological research.
Dr. Mateen has published >150 articles, including research manuscripts, reviews, and editorials.
- Sep | 2 | 2019
The Global Neurology Research Group has created a multilingual coloring book to explain epilepsy to children around the world and reduce myths and stigma surrounding seizure disorders.
- Sep | 20 | 2017
In recognition of National Multiple Sclerosis Awareness month, Farrah Mateen, MD, PhD, of the Multiple Sclerosis Clinic at Massachusetts General Hospital, discusses treatment options for MS patients.
- May | 8 | 2019
Farrah Mateen, MD, PhD, divides her time between seeing patients at Massachusetts General Hospital and traveling across the globe researching innovative solutions for global neurological care.